Loading…
Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system
Serum lipoproteins and cardiovascular risk are affected by endogenous and exogenous sex hormones. As part of a multicenter evaluation of a permeation-enhanced testosterone transdermal system (TTD), the interrelationships among serum lipoproteins, hormone levels, anthropometric parameters, and age we...
Saved in:
| Published in: | The journal of clinical endocrinology and metabolism 2001-03, Vol.86 (3), p.1026-1033 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c315t-c43046892feaf2f6b44f162a6de062da21f607cac7e59cad12763ea3ac40a5cd3 |
|---|---|
| cites | |
| container_end_page | 1033 |
| container_issue | 3 |
| container_start_page | 1026 |
| container_title | The journal of clinical endocrinology and metabolism |
| container_volume | 86 |
| creator | DOBS, Adrian S BACHORIK, Paul S ARVER, Stefan MEIKLE, A. Wayne SANDERS, Steven W CARAMELLI, Kim E MAZER, Norman A |
| description | Serum lipoproteins and cardiovascular risk are affected by endogenous and exogenous sex hormones. As part of a multicenter evaluation of a permeation-enhanced testosterone transdermal system (TTD), the interrelationships among serum lipoproteins, hormone levels, anthropometric parameters, and age were investigated in 29 hypogonadal men. Subjects (aged 21-65 yr) were first studied during prior treatment with im testosterone esters (IM-T), then during an 8-week period of androgen withdrawal resulting in a hypogonadal state (HG), and finally during a 1-yr treatment period with the TTD. Compared with treatment with IM-T, the HG period produced increases in high density lipoprotein [HDL; 12.0 +/- 1.6% (+/-SEM); P |
| doi_str_mv | 10.1210/jc.86.3.1026 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70663699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70663699</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-c43046892feaf2f6b44f162a6de062da21f607cac7e59cad12763ea3ac40a5cd3</originalsourceid><addsrcrecordid>eNpFkcFu1DAQhi0EotvCjTOyhMSpWTx24iRHVEGpVIkLSNyiqT3eZJXYwfYW9uV4Ntx2BafxeL75ZzQ_Y29AbEGC-LA3205v1RaE1M_YBvq6qVro2-dsI4SEqm_ljzN2ntJeCKjrRr1kZwBSdXUHG_bnxmeKkWbMU_BpnNbEcQl-x-dpDWsMmSbPZ7qnOV3yRL_5GGKpU8nQ5zGGNSyU42T4ihHLk-JjyXLcES-943ENu-DR4swX8jxHwkyWuxA58CNh5L-mPHLkK8WFHveoyI_oTaEypRxSES0jSyv6ZAtVpNKx_C6v2AuHc6LXp3jBvn_-9O3qS3X79frm6uNtZRQ0uTK1ErXueukInXT6rq4daInaktDSogSnRWvQtNT0Bi3IVitChaYW2BirLtj7J91ykZ-HstOwTMnQPKOncEhDK7RWuu8LePkEmhhSiuSGNU4LxuMAYnjwa9ibodODGh78Kvjbk-7hbiH7Hz4ZVIB3JwCTwdmVC5gp_eN6AK1a9Re0Q6PX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70663699</pqid></control><display><type>article</type><title>Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system</title><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>DOBS, Adrian S ; BACHORIK, Paul S ; ARVER, Stefan ; MEIKLE, A. Wayne ; SANDERS, Steven W ; CARAMELLI, Kim E ; MAZER, Norman A</creator><creatorcontrib>DOBS, Adrian S ; BACHORIK, Paul S ; ARVER, Stefan ; MEIKLE, A. Wayne ; SANDERS, Steven W ; CARAMELLI, Kim E ; MAZER, Norman A</creatorcontrib><description>Serum lipoproteins and cardiovascular risk are affected by endogenous and exogenous sex hormones. As part of a multicenter evaluation of a permeation-enhanced testosterone transdermal system (TTD), the interrelationships among serum lipoproteins, hormone levels, anthropometric parameters, and age were investigated in 29 hypogonadal men. Subjects (aged 21-65 yr) were first studied during prior treatment with im testosterone esters (IM-T), then during an 8-week period of androgen withdrawal resulting in a hypogonadal state (HG), and finally during a 1-yr treatment period with the TTD. Compared with treatment with IM-T, the HG period produced increases in high density lipoprotein [HDL; 12.0 +/- 1.6% (+/-SEM); P<0.001] and total cholesterol (4.2 +/- 1.9%; P: = 0.02) and a decrease in the cholesterol/HDL ratio (-9.7 +/- 2.8%; P = 0.02). Compared with the HG period, TTD treatment produced decreases in HDL (-7.6 +/- 2.5%; P = 0.002) and increases in the cholesterol/HDL ratio (9.0 +/- 2.5%; P = 0.01) and triglycerides (20.7 +/- 6.4%; P: = 0.03). Small decreases in total cholesterol (-1.2 +/- 1.8%; P: = 0.1) and low density lipoprotein (-0.8 +/- 2.6%; P = 0.07) were also observed during TTD, but did not reach statistical significance. Likewise, there were no significant differences between the IM-T and TTD treatments. Serum HDL levels showed a strong negative correlation with body mass index and other obesity parameters in all three study periods (r < -0.45; P < 0.02). During treatment with TTD, serum testosterone levels also correlated negatively with body mass index (r = -0.621; P < 0.001). As a consequence of these relationships, a positive trend was observed between HDL and testosterone levels during TTD treatment (r = 0.336; P = 0.07). Interestingly, the changes in lipoprotein levels during TTD treatment indicated a more favorable profile (decrease in cholesterol and low density lipoprotein levels) with increasing age of the patients. In hypogonadal men the effects of transdermal testosterone replacement on serum lipoproteins appear consistent with the physiological effects of testosterone in eugonadal men.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.86.3.1026</identifier><identifier>PMID: 11238481</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Administration, Cutaneous ; Adult ; Aged ; Aging ; Anthropometry ; Biological and medical sciences ; Cholesterol - blood ; Dihydrotestosterone - blood ; Estradiol - blood ; Genital system. Reproduction ; Gonadal Steroid Hormones - blood ; Humans ; Hypogonadism - drug therapy ; Hypogonadism - physiopathology ; Lipoproteins - blood ; Lipoproteins, HDL - blood ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Sex Hormone-Binding Globulin - analysis ; Testosterone - administration & dosage ; Testosterone - blood ; Testosterone - therapeutic use</subject><ispartof>The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1026-1033</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-c43046892feaf2f6b44f162a6de062da21f607cac7e59cad12763ea3ac40a5cd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=911637$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11238481$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DOBS, Adrian S</creatorcontrib><creatorcontrib>BACHORIK, Paul S</creatorcontrib><creatorcontrib>ARVER, Stefan</creatorcontrib><creatorcontrib>MEIKLE, A. Wayne</creatorcontrib><creatorcontrib>SANDERS, Steven W</creatorcontrib><creatorcontrib>CARAMELLI, Kim E</creatorcontrib><creatorcontrib>MAZER, Norman A</creatorcontrib><title>Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Serum lipoproteins and cardiovascular risk are affected by endogenous and exogenous sex hormones. As part of a multicenter evaluation of a permeation-enhanced testosterone transdermal system (TTD), the interrelationships among serum lipoproteins, hormone levels, anthropometric parameters, and age were investigated in 29 hypogonadal men. Subjects (aged 21-65 yr) were first studied during prior treatment with im testosterone esters (IM-T), then during an 8-week period of androgen withdrawal resulting in a hypogonadal state (HG), and finally during a 1-yr treatment period with the TTD. Compared with treatment with IM-T, the HG period produced increases in high density lipoprotein [HDL; 12.0 +/- 1.6% (+/-SEM); P<0.001] and total cholesterol (4.2 +/- 1.9%; P: = 0.02) and a decrease in the cholesterol/HDL ratio (-9.7 +/- 2.8%; P = 0.02). Compared with the HG period, TTD treatment produced decreases in HDL (-7.6 +/- 2.5%; P = 0.002) and increases in the cholesterol/HDL ratio (9.0 +/- 2.5%; P = 0.01) and triglycerides (20.7 +/- 6.4%; P: = 0.03). Small decreases in total cholesterol (-1.2 +/- 1.8%; P: = 0.1) and low density lipoprotein (-0.8 +/- 2.6%; P = 0.07) were also observed during TTD, but did not reach statistical significance. Likewise, there were no significant differences between the IM-T and TTD treatments. Serum HDL levels showed a strong negative correlation with body mass index and other obesity parameters in all three study periods (r < -0.45; P < 0.02). During treatment with TTD, serum testosterone levels also correlated negatively with body mass index (r = -0.621; P < 0.001). As a consequence of these relationships, a positive trend was observed between HDL and testosterone levels during TTD treatment (r = 0.336; P = 0.07). Interestingly, the changes in lipoprotein levels during TTD treatment indicated a more favorable profile (decrease in cholesterol and low density lipoprotein levels) with increasing age of the patients. In hypogonadal men the effects of transdermal testosterone replacement on serum lipoproteins appear consistent with the physiological effects of testosterone in eugonadal men.</description><subject>Administration, Cutaneous</subject><subject>Adult</subject><subject>Aged</subject><subject>Aging</subject><subject>Anthropometry</subject><subject>Biological and medical sciences</subject><subject>Cholesterol - blood</subject><subject>Dihydrotestosterone - blood</subject><subject>Estradiol - blood</subject><subject>Genital system. Reproduction</subject><subject>Gonadal Steroid Hormones - blood</subject><subject>Humans</subject><subject>Hypogonadism - drug therapy</subject><subject>Hypogonadism - physiopathology</subject><subject>Lipoproteins - blood</subject><subject>Lipoproteins, HDL - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Sex Hormone-Binding Globulin - analysis</subject><subject>Testosterone - administration & dosage</subject><subject>Testosterone - blood</subject><subject>Testosterone - therapeutic use</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkcFu1DAQhi0EotvCjTOyhMSpWTx24iRHVEGpVIkLSNyiqT3eZJXYwfYW9uV4Ntx2BafxeL75ZzQ_Y29AbEGC-LA3205v1RaE1M_YBvq6qVro2-dsI4SEqm_ljzN2ntJeCKjrRr1kZwBSdXUHG_bnxmeKkWbMU_BpnNbEcQl-x-dpDWsMmSbPZ7qnOV3yRL_5GGKpU8nQ5zGGNSyU42T4ihHLk-JjyXLcES-943ENu-DR4swX8jxHwkyWuxA58CNh5L-mPHLkK8WFHveoyI_oTaEypRxSES0jSyv6ZAtVpNKx_C6v2AuHc6LXp3jBvn_-9O3qS3X79frm6uNtZRQ0uTK1ErXueukInXT6rq4daInaktDSogSnRWvQtNT0Bi3IVitChaYW2BirLtj7J91ykZ-HstOwTMnQPKOncEhDK7RWuu8LePkEmhhSiuSGNU4LxuMAYnjwa9ibodODGh78Kvjbk-7hbiH7Hz4ZVIB3JwCTwdmVC5gp_eN6AK1a9Re0Q6PX</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>DOBS, Adrian S</creator><creator>BACHORIK, Paul S</creator><creator>ARVER, Stefan</creator><creator>MEIKLE, A. Wayne</creator><creator>SANDERS, Steven W</creator><creator>CARAMELLI, Kim E</creator><creator>MAZER, Norman A</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010301</creationdate><title>Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system</title><author>DOBS, Adrian S ; BACHORIK, Paul S ; ARVER, Stefan ; MEIKLE, A. Wayne ; SANDERS, Steven W ; CARAMELLI, Kim E ; MAZER, Norman A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-c43046892feaf2f6b44f162a6de062da21f607cac7e59cad12763ea3ac40a5cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Administration, Cutaneous</topic><topic>Adult</topic><topic>Aged</topic><topic>Aging</topic><topic>Anthropometry</topic><topic>Biological and medical sciences</topic><topic>Cholesterol - blood</topic><topic>Dihydrotestosterone - blood</topic><topic>Estradiol - blood</topic><topic>Genital system. Reproduction</topic><topic>Gonadal Steroid Hormones - blood</topic><topic>Humans</topic><topic>Hypogonadism - drug therapy</topic><topic>Hypogonadism - physiopathology</topic><topic>Lipoproteins - blood</topic><topic>Lipoproteins, HDL - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Sex Hormone-Binding Globulin - analysis</topic><topic>Testosterone - administration & dosage</topic><topic>Testosterone - blood</topic><topic>Testosterone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DOBS, Adrian S</creatorcontrib><creatorcontrib>BACHORIK, Paul S</creatorcontrib><creatorcontrib>ARVER, Stefan</creatorcontrib><creatorcontrib>MEIKLE, A. Wayne</creatorcontrib><creatorcontrib>SANDERS, Steven W</creatorcontrib><creatorcontrib>CARAMELLI, Kim E</creatorcontrib><creatorcontrib>MAZER, Norman A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DOBS, Adrian S</au><au>BACHORIK, Paul S</au><au>ARVER, Stefan</au><au>MEIKLE, A. Wayne</au><au>SANDERS, Steven W</au><au>CARAMELLI, Kim E</au><au>MAZER, Norman A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2001-03-01</date><risdate>2001</risdate><volume>86</volume><issue>3</issue><spage>1026</spage><epage>1033</epage><pages>1026-1033</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Serum lipoproteins and cardiovascular risk are affected by endogenous and exogenous sex hormones. As part of a multicenter evaluation of a permeation-enhanced testosterone transdermal system (TTD), the interrelationships among serum lipoproteins, hormone levels, anthropometric parameters, and age were investigated in 29 hypogonadal men. Subjects (aged 21-65 yr) were first studied during prior treatment with im testosterone esters (IM-T), then during an 8-week period of androgen withdrawal resulting in a hypogonadal state (HG), and finally during a 1-yr treatment period with the TTD. Compared with treatment with IM-T, the HG period produced increases in high density lipoprotein [HDL; 12.0 +/- 1.6% (+/-SEM); P<0.001] and total cholesterol (4.2 +/- 1.9%; P: = 0.02) and a decrease in the cholesterol/HDL ratio (-9.7 +/- 2.8%; P = 0.02). Compared with the HG period, TTD treatment produced decreases in HDL (-7.6 +/- 2.5%; P = 0.002) and increases in the cholesterol/HDL ratio (9.0 +/- 2.5%; P = 0.01) and triglycerides (20.7 +/- 6.4%; P: = 0.03). Small decreases in total cholesterol (-1.2 +/- 1.8%; P: = 0.1) and low density lipoprotein (-0.8 +/- 2.6%; P = 0.07) were also observed during TTD, but did not reach statistical significance. Likewise, there were no significant differences between the IM-T and TTD treatments. Serum HDL levels showed a strong negative correlation with body mass index and other obesity parameters in all three study periods (r < -0.45; P < 0.02). During treatment with TTD, serum testosterone levels also correlated negatively with body mass index (r = -0.621; P < 0.001). As a consequence of these relationships, a positive trend was observed between HDL and testosterone levels during TTD treatment (r = 0.336; P = 0.07). Interestingly, the changes in lipoprotein levels during TTD treatment indicated a more favorable profile (decrease in cholesterol and low density lipoprotein levels) with increasing age of the patients. In hypogonadal men the effects of transdermal testosterone replacement on serum lipoproteins appear consistent with the physiological effects of testosterone in eugonadal men.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>11238481</pmid><doi>10.1210/jc.86.3.1026</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0021-972X |
| ispartof | The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1026-1033 |
| issn | 0021-972X 1945-7197 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70663699 |
| source | Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list) |
| subjects | Administration, Cutaneous Adult Aged Aging Anthropometry Biological and medical sciences Cholesterol - blood Dihydrotestosterone - blood Estradiol - blood Genital system. Reproduction Gonadal Steroid Hormones - blood Humans Hypogonadism - drug therapy Hypogonadism - physiopathology Lipoproteins - blood Lipoproteins, HDL - blood Male Medical sciences Middle Aged Pharmacology. Drug treatments Sex Hormone-Binding Globulin - analysis Testosterone - administration & dosage Testosterone - blood Testosterone - therapeutic use |
| title | Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A03%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interrelationships%20among%20lipoprotein%20levels,%20sex%20hormones,%20anthropometric%20parameters,%20and%20age%20in%20hypogonadal%20men%20treated%20for%201%20year%20with%20a%20permeation-enhanced%20testosterone%20transdermal%20system&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=DOBS,%20Adrian%20S&rft.date=2001-03-01&rft.volume=86&rft.issue=3&rft.spage=1026&rft.epage=1033&rft.pages=1026-1033&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.86.3.1026&rft_dat=%3Cproquest_cross%3E70663699%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c315t-c43046892feaf2f6b44f162a6de062da21f607cac7e59cad12763ea3ac40a5cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70663699&rft_id=info:pmid/11238481&rfr_iscdi=true |